MOXIFLOXACIN PF- moxifloxacin pf injection, solution
ImprimisRx NJ

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

Store at 20° to 25° C (68° to 77° F)

Vial Label

Vial Label

MOXIFLOXACIN PF
moxifloxacin pf injection, solution

Product Information
Product Type	HUMAN PRESCRIPTION DRUG	Item Code (Source)	NDC:70261-511
Route of Administration	INTRAOCULAR

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
MOXIFLOXACIN HYDROCHLORIDE MONOHYDRATE (UNII: B8956S8609) (MOXIFLOXACIN - UNII:U188XYD42P)	MOXIFLOXACIN	5 mg in 1 mL

Ingredient Name	Strength
Inactive Ingredients
SODIUM CHLORIDE (UNII: 451W47IQ8X)	8 mg in 1 mL

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:70261-511-01	1 mL in 1 VIAL, GLASS; Type 0: Not a Combination Product	01/01/2018

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
unapproved drug other		01/01/2018

Labeler - ImprimisRx NJ (931390178)

Registrant - ImprimisRx NJ (931390178)

Name	Address	ID/FEI	Business Operations
Establishment
Imprimis Pharmaceuticals		080431967	manufacture(70261-511)

Revised: 5/2018

Document Id: 6bb744c0-b613-2858-e053-2991aa0ae715

Set id: 6bb744c0-b612-2858-e053-2991aa0ae715

Version: 1

Effective Time: 20180508

ImprimisRx NJ